Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Jazz Pharmaceuticals
Pharma
Jazz's almost-withdrawn lung cancer drug shows life
Jazz proposed two phase 3 trials to keep Zepzelca's accelerated approval a few years ago, and one of them has read out positively.
Angus Liu
Oct 15, 2024 10:15am
Sanofi, DualityBio, UCB—Fierce Pharma Asia
Aug 30, 2024 8:05am
Jazz's Epidiolex fails trial in treatment-resistant epilepsies
Aug 23, 2024 10:18am
Jazz hands chief commercial role to Samantha Pearce
Jul 9, 2024 9:15am
Jazz weighs options, including possible sale: Bloomberg
Oct 20, 2023 11:18am
Jazz Pharma, focused on launches, reveals some exec changes
Sep 12, 2023 1:55pm
